NDC directory

Amyloid Beta-directed Antibodies list

Every FDA-approved prescription drug the FDA NDC directory tags with the Amyloid Beta-directed Antibody [EPC] class, with brand names and DEA schedules.

Source: FDA NDC Directory file dated 2026-10-22. Publisher page

RUN IT IN RIVVI

Map Leqembi and your other top fills to their generics

Rivvi lists each brand, its generics in RxNorm, and the brands with no generic.

Map my fills

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

2M+ interactions500K+ patientsHIPAA BAA

The FDA NDC directory lists 2 single-ingredient drugs in this class: lecanemab, lecanemab-irmb.

Amyloid Beta-directed Antibodies (2)

Amyloid Beta-directed Antibodies: FDA Amyloid Beta-directed Antibody class
DrugBrand namesTypeNDC listingsDEA schedule
LecanemabLeqembiSingle ingredient2Not controlled
Lecanemab-irmbLecanemab AutoinjectorSingle ingredient2Not controlled

FDA established pharmacologic class: Amyloid Beta-directed Antibody [EPC].

Ask Rivvi

Ask about this drug class.

Opens a workspace. Rivvi explains the public drug-class record. It does not give dosing or medical advice.

Questions

What drugs are Amyloid Beta-directed Antibodies?

The FDA NDC directory lists 2 single-ingredient drugs in this class: lecanemab, lecanemab-irmb.

Where does this list come from?

From the established pharmacologic class (EPC) field FDA publishes for each listing in the NDC directory. A drug is listed when most of its prescription listings carry the class.

Related

RUN IT IN RIVVI

Map Leqembi and your other top fills to their generics

Rivvi lists each brand, its generics in RxNorm, and the brands with no generic.

Map my fills

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

2M+ interactions500K+ patientsHIPAA BAA

Try it on your own data today.

Free to start. Most teams are using it the same day.